The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation

Clinical trial NCT05262608 · UNKNOWN

Trial details

NCT number: NCT05262608
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostate Carcinoma Metastatic Castration-resistant Prostate Cancer

Start date: 2021-12-07
Primary completion: 2024-02-26
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.